← Home

CUV

Healthcare & BiotechDOWNTREND

$8.160

as of 2026-09-09

5d return

-1.8%

20d return

-13.6%

60d return

-16.1%

RSI 14

17.5

vs 52w high

-38.0%

vs 52w low

+2.4%

SMA 20

Below

SMA 50

Below

Price · Volume · Broker flow
Markers = announcements (red triangle = price-sensitive). Volume amber = ≥2× ADV spike.
Loading chart…
Closest correlates
Pearson r on log returns, window: 82d
  • DEVr=0.42, window: 82d
  • 4DXr=0.38, window: 82d
  • LACr=0.36, window: 82d
  • AR3r=0.34, window: 82d
  • MQRr=0.29, window: 82d
Announcements — last 30 days
  • 2026-09-02PSsubstantial_holderCeasing to be a substantial holder

    Vanguard exited below its entry (avg ~9.55 AUD, exit 9.18 AUD) after a 22% 5-day pullback and 9% 20-day decline, signalling either opportunistic trimming or loss of conviction in a stock down 38% from 252d highs. The exit itself is mechanically bearish—a major institutional supporter reducing weight—but the timing into a 5-session run-up in retail/MM flow suggests potential capitulation wash rather than a genuine catalyst.

  • 2026-08-14PSsubstantial_holderBecoming a substantial holder

    Vanguard has crossed the 5% substantial holder threshold through steady accumulation over four months at ~$9.50, signalling institutional confidence in CUV's pipeline or valuation. The holding is passive (fund management mandate) rather than strategic, but validates market positioning ahead of potential clinical or commercial milestones.